> top > docs > PubMed:22966989 > annotations

PubMed:22966989 JSONTXT

Annnotations TAB JSON ListView MergeView

PubMed_Structured_Abstracts

Id Subject Object Predicate Lexical cue
T1 122-1024 BACKGROUND denotes Central post-stroke pain (CPSP) is a neuropathic pain syndrome associated with somatosensory abnormalities due to central nervous system lesion following a cerebrovascular insult. Post-stroke pain (PSP) refers to a broader range of clinical conditions leading to pain after stroke, but not restricted to CPSP, including other types of pain such as myofascial pain syndrome (MPS), painful shoulder, lumbar and dorsal pain, complex regional pain syndrome, and spasticity-related pain. Despite its recognition as part of the general PSP diagnostic possibilities, the prevalence of MPS has never been characterized in patients with CPSP patients. We performed a cross-sectional standardized clinical and radiological evaluation of patients with definite CPSP in order to assess the presence of other non-neuropathic pain syndromes, and in particular, the role of myofascial pain syndrome in these patients.
T2 1034-1353 METHODS denotes CPSP patients underwent a standardized sensory and motor neurological evaluation, and were classified according to stroke mechanism, neurological deficits, presence and profile of MPS. The Visual Analogic Scale (VAS), McGill Pain Questionnaire (MPQ), and Beck Depression Scale (BDS) were filled out by all participants.
T3 1363-2232 RESULTS denotes Forty CPSP patients were included. Thirty-six (90.0%) had one single ischemic stroke. Pain presented during the first three months after stroke in 75.0%. Median pain intensity was 10 (5 to 10). There was no difference in pain intensity among the different lesion site groups. Neuropathic pain was continuous-ongoing in 34 (85.0%) patients and intermittent in the remainder. Burning was the most common descriptor (70%). Main aggravating factors were contact to cold (62.5%). Thermo-sensory abnormalities were universal. MPS was diagnosed in 27 (67.5%) patients and was more common in the supratentorial extra-thalamic group (P <0.001). No significant differences were observed among the different stroke location groups and pain questionnaires and scales scores. Importantly, CPSP patients with and without MPS did not differ in pain intensity (VAS), MPQ or BDS scores.
T4 2246-2437 CONCLUSIONS denotes The presence of MPS is not an exception after stroke and may present in association with CPSP as a common comorbid condition. Further studies are necessary to clarify the role of MPS in CPSP.

NEUROSES

Id Subject Object Predicate Lexical cue
T1 61-69 PATO_0000070 denotes presence
T2 900-908 PATO_0000070 denotes presence
T3 1190-1198 PATO_0000070 denotes presence
T4 2250-2258 PATO_0000070 denotes presence
T5 73-83 PATO_0001668 denotes associated
T7 320-323 CHEBI_31991 denotes PSP
T8 652-655 CHEBI_31991 denotes PSP
T9 531-537 PATO_0001233 denotes dorsal
T10 544-551 PATO_0001504 denotes complex
T11 780-795 PATO_0002006 denotes cross-sectional
T12 973-977 CHEBI_50906 denotes role
T13 2417-2421 CHEBI_50906 denotes role
T14 1223-1229 PATO_0000234 denotes Visual
T15 1312-1315 CHEBI_72752 denotes BDS
T16 2221-2224 CHEBI_72752 denotes BDS
T17 1529-1538 PATO_0000049 denotes intensity
T18 1589-1598 PATO_0000049 denotes intensity
T19 2197-2206 PATO_0000049 denotes intensity
T20 1660-1670 PATO_0000689 denotes continuous
T21 1706-1718 PATO_0000690 denotes intermittent
T22 1824-1828 PATO_0001306 denotes cold
T23 1981-1986 CHEBI_24433 denotes group
T24 2067-2075 PATO_0000605 denotes location
T25 2067-2075 PATO_0000140 denotes location
T26 2174-2177 CHEBI_52027 denotes did
T27 2307-2314 PATO_0000467 denotes present
T28 1294-1304 PM3425 denotes Depression
T29 1294-1304 PM3425 denotes Depression

Allie

Id Subject Object Predicate Lexical cue
SS1_22966989_2_0 122-146 expanded denotes Central post-stroke pain
SS2_22966989_2_0 148-152 abbr denotes CPSP
SS1_22966989_3_0 302-318 expanded denotes Post-stroke pain
SS2_22966989_3_0 320-323 abbr denotes PSP
SS1_22966989_3_1 470-494 expanded denotes myofascial pain syndrome
SS2_22966989_3_1 496-499 abbr denotes MPS
SS1_22966989_8_0 1223-1244 expanded denotes Visual Analogic Scale
SS2_22966989_8_0 1246-1249 abbr denotes VAS
SS1_22966989_8_1 1252-1277 expanded denotes McGill Pain Questionnaire
SS2_22966989_8_1 1279-1282 abbr denotes MPQ
SS1_22966989_8_2 1289-1310 expanded denotes Beck Depression Scale
SS2_22966989_8_2 1312-1315 abbr denotes BDS
AE1_22966989_2_0 SS1_22966989_2_0 SS2_22966989_2_0 abbreviatedTo Central post-stroke pain,CPSP
AE1_22966989_3_0 SS1_22966989_3_0 SS2_22966989_3_0 abbreviatedTo Post-stroke pain,PSP
AE1_22966989_3_1 SS1_22966989_3_1 SS2_22966989_3_1 abbreviatedTo myofascial pain syndrome,MPS
AE1_22966989_8_0 SS1_22966989_8_0 SS2_22966989_8_0 abbreviatedTo Visual Analogic Scale,VAS
AE1_22966989_8_1 SS1_22966989_8_1 SS2_22966989_8_1 abbreviatedTo McGill Pain Questionnaire,MPQ
AE1_22966989_8_2 SS1_22966989_8_2 SS2_22966989_8_2 abbreviatedTo Beck Depression Scale,BDS

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 135-141 HP_0001297 denotes stroke
T2 142-146 HP_0012531 denotes pain
T3 171-175 HP_0012531 denotes pain
T4 307-313 HP_0001297 denotes stroke
T5 314-318 HP_0012531 denotes pain
T6 385-389 HP_0012531 denotes pain
T7 396-402 HP_0001297 denotes stroke
T8 457-461 HP_0012531 denotes pain
T9 481-485 HP_0012531 denotes pain
T10 502-509 HP_0012531 denotes painful
T11 538-542 HP_0012531 denotes pain
T12 561-565 HP_0012531 denotes pain
T13 580-590 HP_0001257 denotes spasticity
T14 599-603 HP_0012531 denotes pain
T15 934-938 HP_0012531 denotes pain
T16 992-996 HP_0012531 denotes pain